Pain Drug Co. Treated To Shareholder Suit Over Exec's Exit
A corporate shareholder hit NeurogesX Inc. with a proposed securities class action Monday in New York federal court, claiming the biopharmaceutical developer fraudulently deceived investors and sent the stock plummeting by...To view the full article, register now.
Already a subscriber? Click here to view full article